159 related articles for article (PubMed ID: 25098973)
1. Viral entry inhibition: too late for hepatitis C, but promising for other viral infections.
Pawlotsky JM
Gut; 2015 Mar; 64(3):362-4. PubMed ID: 25098973
[No Abstract] [Full Text] [Related]
2. Inhibition of hepatitis C entry: too soon to dismiss while many are still being denied treatment.
Uprichard SL; Sainz B
Gut; 2015 Apr; 64(4):690-1. PubMed ID: 25287483
[No Abstract] [Full Text] [Related]
3. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors.
Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J
Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883
[TBL] [Abstract][Full Text] [Related]
4. New perspectives in HCV therapy: entry inhibitors.
Donia M; Cacopardo B; Libra M; Scalia G; McCubrey JA; Nicoletti F
Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):181-94. PubMed ID: 20497122
[TBL] [Abstract][Full Text] [Related]
5. Entry inhibitors and future treatment of hepatitis C.
Fofana I; Jilg N; Chung RT; Baumert TF
Antiviral Res; 2014 Apr; 104():136-42. PubMed ID: 24525381
[TBL] [Abstract][Full Text] [Related]
6. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
Mittapalli GK; Jackson A; Zhao F; Lee H; Chow S; McKelvy J; Wong-Staal F; Macdonald JE
Bioorg Med Chem Lett; 2011 Nov; 21(22):6852-5. PubMed ID: 21978675
[TBL] [Abstract][Full Text] [Related]
7. Curcumin against hepatitis C virus infection: spicing up antiviral therapies with 'nutraceuticals'?
Pécheur EI
Gut; 2014 Jul; 63(7):1035-7. PubMed ID: 24092864
[No Abstract] [Full Text] [Related]
8. (4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry.
Chung CY; Liu CH; Wang GH; Jassey A; Li CL; Chen L; Yen MH; Lin CC; Lin LT
Sci Rep; 2016 Jul; 6():29969. PubMed ID: 27426693
[TBL] [Abstract][Full Text] [Related]
9. Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases.
Pietschmann T
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807238
[TBL] [Abstract][Full Text] [Related]
10. Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.
Xiao F; Fofana I; Thumann C; Mailly L; Alles R; Robinet E; Meyer N; Schaeffer M; Habersetzer F; Doffoël M; Leyssen P; Neyts J; Zeisel MB; Baumert TF
Gut; 2015 Mar; 64(3):483-94. PubMed ID: 24848265
[TBL] [Abstract][Full Text] [Related]
11. Entry inhibitors: New advances in HCV treatment.
Qian XJ; Zhu YZ; Zhao P; Qi ZT
Emerg Microbes Infect; 2016 Jan; 5(1):e3. PubMed ID: 26733381
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus entry.
Zeisel MB; Felmlee DJ; Baumert TF
Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
[TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors
Koutsoudakis G; Paris de León A; Herrera C; Dorner M; Pérez-Vilaró G; Lyonnais S; Grijalvo S; Eritja R; Meyerhans A; Mirambeau G; Díez J
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193659
[TBL] [Abstract][Full Text] [Related]
14. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.
Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP
Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825
[TBL] [Abstract][Full Text] [Related]
15. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
[TBL] [Abstract][Full Text] [Related]
16. How does interferon inhibit HCV cell entry?
Jones M; Owen JS
Gut; 2008 May; 57(5):573-4. PubMed ID: 18408099
[No Abstract] [Full Text] [Related]
17. ["Entry inhibitors" prevent virus access to the cell]].
Fessler B
MMW Fortschr Med; 2015 Mar; 157 Suppl 1():86. PubMed ID: 26012995
[No Abstract] [Full Text] [Related]
18. [Research on hepatitis C virus entry inhibitor].
Zeng Wenting ; Lu X; Wang J; Jin X; Zhu J
Bing Du Xue Bao; 2015 Jan; 31(1):97-105. PubMed ID: 25997338
[TBL] [Abstract][Full Text] [Related]
19. Gumming up the works: DNA polymers as HCV entry inhibitors.
Counihan NA; Lindenbach BD
Gastroenterology; 2009 Aug; 137(2):427-30. PubMed ID: 19563837
[No Abstract] [Full Text] [Related]
20. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.
Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J
J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]